CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- ARS Other Annual Report to Security Holders
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 5 of 64 · 1,274 filings